Mixed conductive and sensorineural hearing loss

H8_HL_MIX_NAS

sensorineural hearing loss: Hearing loss in which the root cause lies in the inner ear or sensory organ (cochlea and associated structures) or the vestibulocochlear nerve (cranial nerve VIII).

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H90.6, H90.7, H90.8 Hospital discharge: ICD-9 — 3892 Cause of death: ICD-10 — H90.6, H90.7, H90.8 Cause of death: ICD-9 — 3892 2 out of 7 registries used, show all original rules.	5011
4. Check minimum number of events None	5011
5. Include endpoints None	5011
6. Filter based on genotype QC (FinnGen only)	5011

Control definitions (FinnGen only)

Control exclude: H8_OTHEREAR

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	H8_HL_MIX_NAS
CONTROL_EXCLUDE	H8_OTHEREAR
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H90[6-8]
HD_ICD_9	3892
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H90[6-8]
COD_ICD_9	3892
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Mixed conductive and sensorineural hearing loss based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	36727	19869	16663
Only index persons	34045	18719	15326
Unadjusted period prevalence (%)
Whole population	0.52	0.57	0.47
Only index persons	0.64	0.69	0.59
Median age at first event (years)
Whole population	62.97	63.35	62.45
Only index persons	62.24	62.65	61.74

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5011	2687	2324
Unadjusted period prevalence (%)	0.97	0.92	1.02
Median age at first event (years)	61.58	59.59	63.87

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4477: Matched controls
44770

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

DFF00

NOMESCO Finland

Pure tone audiometry

35.1

323.0

1477

619

H80.9

ICD-10 Finland

Otosclerosis, unspecified

94.6

323.0

451

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

46.8

323.0

603

148

Z01.1

ICD-10 Finland

Examination of ears and hearing

16.4

323.0

1790

1752

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

278.6

323.0

2313

171

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

409.4

323.0

480

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

37.3

323.0

1001

343

Z97.4

ICD-10 Finland

Presence of external hearing-aid

50.8

323.0

849

205

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

149.6

323.0

810

DFF15

NOMESCO Finland

Speech audiometry

32.8

323.0

680

243

UDC00

NOMESCO Finland

Ear microscopy

17.2

323.0

1058

790

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

6507.1

323.0

2581

DAX08

NOMESCO Finland

Fitting of hearing aid

52.9

323.0

605

132

H90.8

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unspecified

672.3

323.0

482

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

428.4

323.0

800

R5120

NOMESCO Finland

Preparation of an aid

26.6

323.0

498

210

DC1AD

NOMESCO Finland

Temporalbone CT

101.4

323.0

355

H80.0

ICD-10 Finland

Otosclerosis involving oval window, nonobliterative

112.0

323.0

435

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

13830.5

323.0

1744

DDA00

NOMESCO Finland

Stapedotomy

125.6

314.3

337

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

37.0

295.5

383

113

H71

ICD-10 Finland

Cholesteatoma of middle ear

45.4

283.9

352

H02

ICPC

Hearing complaint

5.5

275.0

912

1984

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

159.5

270.3

284

Z3229

NOMESCO Finland

Other healthcare associate professional

5.8

255.9

798

1601

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

20.0

248.4

383

208

H91.9

ICD-10 Finland

Hearing loss, unspecified

15.0

248.2

428

313

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

4.6

233.1

923

2395

H93.1

ICD-10 Finland

Tinnitus

11.0

187.2

373

368

R5140

NOMESCO Finland

Monitoring the use of the aid

4.3

179.0

752

2023

H65.3

ICD-10 Finland

Chronic mucoid otitis media

16.9

176.2

288

181

SPAT1043

SPAT

Audiometry

4.6

172.2

663

1633

H91.1

ICD-10 Finland

Presbycusis

8.5

154.9

355

447

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

55.5

139.2

166

R4135

NOMESCO Finland

Rehabilitation for hearing problems

55.5

139.2

166

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

19.6

139.2

215

115

H66.0

ICD-10 Finland

Acute suppurative otitis media

5.6

139.1

433

835

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

13.8

134.9

239

182

N07CA01

ATC

betahistine; oral

4.6

133.5

505

1205

H80.1

ICD-10 Finland

Otosclerosis involving oval window, obliterative

177.6

115.9

121

H65.2

ICD-10 Finland

Chronic serous otitis media

19.0

114.8

179

38110

ICD-8 Finland

Otitis media without mention of mastoiditis, Chronic

22.5

114.7

169

38699

ICD-8 Finland

35.9

112.4

146

TDA90

NOMESCO Finland

Removal wax from ear

18.7

112.2

176

ZXC10

NOMESCO Finland

Use of laser

7.3

102.6

257

368

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

33.2

97.6

129

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.7

95.1

459

1352

DCD00

NOMESCO Finland

Myringoplasty

23.8

91.4

132

H60.9

ICD-10 Finland

Otitis externa, unspecified

3.9

91.4

409

1128

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

22.6

91.4

134

DCD10

NOMESCO Finland

Tympanoplasty

93.0

90.3

100

3870A

ICD-9 Finland

Otosclerosis involving oval window, nonobliterative

33.6

89.7

118

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

2.3

87.6

1001

5034

H29

ICPC

Ear symptom/complaint other

3.0

84.8

554

2033

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

21.6

84.7

126

H74.1

ICD-10 Finland

Adhesive middle ear disease

46.2

84.6

104

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

42.9

84.2

105

H66.9

ICD-10 Finland

Otitis media, unspecified

4.4

83.0

321

772

H80.8

ICD-10 Finland

Other otosclerosis

69.2

82.7

4133

FHL

Stapedectomy sampling

37.6

80.4

103

H81.0

ICD-10 Finland

Ménière disease

8.3

78.9

181

226

H70.1

ICD-10 Finland

Chronic mastoiditis

46.1

77.4

RK520

NOMESCO Finland

42.6

77.0

H90.2

ICD-10 Finland

Conductive hearing loss, unspecified

86.7

76.2

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

5.7

76.0

230

423

DFE00

NOMESCO Finland

Insertion of cochlear implant

+∞

74.2

H61.2

ICD-10 Finland

Impacted cerumen

3.4

67.1

350

1087

38700

ICD-8 Finland

Other disease of ear and mastoid process, Cholesteatoma of ear

31.3

66.7

38210

ICD-8 Finland

Chronic otitis media with mastoiditis

25.3

65.2

DEB25

NOMESCO Finland

Attico-antro-mastoidectomy and tympanoplasty

116.8

64.0

H60.3

ICD-10 Finland

Other infective otitis externa

6.4

63.8

175

284

RK320

NOMESCO Finland

13.8

61.7

108

H13

ICPC

Plugged feeling ear

2.1

60.5

831

4442

Z97.8

ICD-10 Finland

Presence of other specified devices

57.5

57.7

RK110

NOMESCO Finland

13.0

56.9

102

H60.8

ICD-10 Finland

Other otitis externa

5.1

56.5

185

373

H72.9

ICD-10 Finland

Perforation of tympanic membrane, unspecified

13.1

55.9

100

H80

ICD-10 Finland

Otosclerosis

121.6

55.9

3821A

ICD-9 Finland

Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media

23.0

53.2

DDB00

NOMESCO Finland

Stapedectomy

97.9

52.9

S02CA02

ATC

flumetasone and antiinfectives; otic

3.0

52.7

328

1151

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

33.3

52.7

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

52.6

2039

15156

H95.1

ICD-10 Finland

Other disorders following mastoidectomy

+∞

51.1

DBD20

NOMESCO Finland

Plastic repair of external auditory canal

21.8

51.0

RK420

NOMESCO Finland

94.5

50.9

H01

ICPC

Ear pain/earache

2.4

49.8

452

1981

H04

ICPC

Ear discharge

4.1

48.8

200

506

3853A

ICD-9 Finland

Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid

32.4

48.6

DFF10

NOMESCO Finland

Measurement of acoustic impedance (tympanometry and reflex testing)

63.0

48.3

H72.2

ICD-10 Finland

Other marginal perforations of tympanic membrane

22.6

47.5

RK120

NOMESCO Finland

27.5

47.3

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

11.3

47.2

DFX00

NOMESCO Finland

Connecting cochlear implant

+∞

46.9

DCA30

NOMESCO Finland

Exploration of middle ear

165.1

46.9

H81

ICPC

Excessive ear wax

1.9

46.9

756

4258

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

9.3

46.4

107

R42

ICD-10 Finland

Dizziness and giddiness

1.8

46.3

969

5970

H90.5

ICD-10 Finland

Sensorineural hearing loss, unspecified

18.5

45.8

R01AD09

ATC

mometasone; nasal

1.6

45.7

1723

12557

DEA10

NOMESCO Finland

Attico-antrotomy

65.7

45.2

DFF16

NOMESCO Finland

Speech-in-noise audiometry

+∞

44.9

H65.0

ICD-10 Finland

Acute serous otitis media

7.4

44.1

108

150

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.7

43.4

1128

7404

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

10.7

43.3

H92.0

ICD-10 Finland

Otalgia

3.5

41.8

207

616

H74.2

ICD-10 Finland

Discontinuity and dislocation of ear ossicles

55.0

41.5

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

6.3

41.1

112

181

DDD05

NOMESCO Finland

Plastic repair of ossicular chain

111.1

40.8

RK530

NOMESCO Finland

390.8

39.1

R01AD08

ATC

fluticasone; nasal

1.7

38.2

1087

7277

DEB20

NOMESCO Finland

Attico-antro-mastoidectomy and tympanotomy

35.4

38.1

H60

ICD-10 Finland

Otitis externa

3.2

37.9

211

686

N02BE01

ATC

paracetamol; systemic, rectal

1.6

37.1

3646

32603

J01CA04

ATC

amoxicillin; systemic

1.5

36.2

3261

28413

4150

FHL

Tympanoplasty (including for reasons other than inflammation)

48.2

35.7

G47.3

ICD-10 Finland

Sleep apnoea

1.7

35.5

831

5245

RK290

NOMESCO Finland

25.5

34.5

H84

ICPC

Presbyacusis

3.9

34.3

147

388

H66.1

ICD-10 Finland

Chronic tubotympanic suppurative otitis media

17.9

34.0

J01DB01

ATC

cefalexin; oral

1.5

32.9

3363

29726

DEB30

NOMESCO Finland

Radical mastoidectomy

44.8

32.8

S03CA01

ATC

dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

3.6

32.5

152

433

H91

ICD-10 Finland

Other hearing loss

9.8

32.0

A98

ICPC

Health maint/preventive medicine

1.8

31.5

4048

37637

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

6.4

31.2

131

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

31.0

1823

14303

H73.1

ICD-10 Finland

Chronic myringitis

70.4

30.9

H02AB06

ATC

prednisolone; systemic

1.5

30.1

1890

14996

DEE00

NOMESCO Finland

Osseous fixation of hearing aid

304.4

29.8

J01DA01

ATC

[U] cefalexin; systemic

1.4

29.5

2529

21279

4141

FHL

Myringoplasty (also for reasons other than inflammation)

11.9

29.3

H81.3

ICD-10 Finland

Other peripheral vertigo

3.5

29.1

143

424

DEB10

NOMESCO Finland

Attico-antro-mastoidectomy

33.9

28.7

YPA00

NOMESCO Finland

Excision of blood vessel for transplantation

104.1

28.7

H91.8

ICD-10 Finland

Other specified hearing loss

10.5

28.6

H28

ICPC

Limited function/disability (H)

6.9

28.5

106

H90

ICD-10 Finland

Conductive and sensorineural hearing loss

26.2

28.3

H95.0

ICD-10 Finland

Recurrent cholesteatoma of postmastoidectomy cavity

+∞

28.1

H65.9

ICD-10 Finland

Nonsuppurative otitis media, unspecified

10.1

27.6

DFF59

NOMESCO Finland

Other assessment of balance

8.0

27.6

RK220

NOMESCO Finland

12.8

27.0

4145

FHL

Tympanomastoidectomy, includes possible tympanoplasty

41.5

26.7

WX110

NOMESCO Finland

Local anesthesy

1.4

26.7

2642

22616

J01FA10

ATC

azithromycin; systemic

1.4

26.5

2102

17283

H66

ICD-10 Finland

Suppurative and unspecified otitis media

4.1

26.4

105

261

H60.5

ICD-10 Finland

Acute otitis externa, noninfective

6.6

25.5

101

DDD10

NOMESCO Finland

Interposition between malleus and stapes

+∞

25.0

4147

FHL

Radical surgery, cavity filling and middle ear and / or eardrum plastic

39.0

24.9

H74.3

ICD-10 Finland

Other acquired abnormalities of ear ossicles

90.6

24.7

DDW99

NOMESCO Finland

Other operation on ossicles of ear

90.6

24.7

R01AD12

ATC

fluticasone furoate; nasal

1.5

24.2

969

6935

DGW00

NOMESCO Finland

Dilatation of eustachian tube

29.3

24.0

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.2

23.7

254

1200

H61.3

ICD-10 Finland

Acquired stenosis of external ear canal

14.0

23.0

H95.8

ICD-10 Finland

Other postprocedural disorders of ear and mastoid process

+∞

22.9

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

2.8

22.9

148

533

SPAT1301

SPAT

No procedures

1.4

22.6

1266

9677

J01MA02

ATC

ciprofloxacin; systemic

1.4

22.5

1573

12515

R03AC02

ATC

salbutamol; inhalant

1.4

22.3

1970

16311

AA1AD

NOMESCO Finland

CT of head and brain

1.5

22.2

963

6986

SPAT1041

SPAT

Comprehensive hearing test

5.8

22.1

110

H72

ICD-10 Finland

Perforation of tympanic membrane

21.5

22.1

38990

ICD-8 Finland

Other deafness, Partialis uni-sive bilateralis

+∞

21.9

H66.2

ICD-10 Finland

Chronic atticoantral suppurative otitis media

62.8

21.8

H60.4

ICD-10 Finland

Cholesteatoma of external ear

17.1

21.7

H80.20

ICD-10 Finland

Otosclerosis involving round window

80.5

21.7

H72.8

ICD-10 Finland

Other perforations of tympanic membrane

12.8

21.6

DE2CM

NOMESCO Finland

Acoustic channel extensive MRI examination with 3 Tesla magnet

43.5

21.4

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

21.3

1136

8584

ZXA00

NOMESCO Finland

Right side

1.4

21.1

1134

8584

38401

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva

13.4

20.9

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

20.4

1656

13455

38199

ICD-8 Finland

Otitis media without mention of mastoiditis, Unspecified

13.1

20.1

4143

FHL

Atticotomy or atticoanthromy through the ear canal

57.8

19.9

ZXA10

NOMESCO Finland

Bilateral

1.5

19.9

759

5348

DCW99

NOMESCO Finland

Other operation on eardrum and middle ear

35.9

19.8

Z45.3

ICD-10 Finland

Adjustment and management of implanted hearing device

+∞

19.8

4151

FHL

Reoperation for chronic otitis media

29.0

19.6

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.6

19.6

629

4258

Q16.1

ICD-10 Finland

Congenital absence, atresia and stricture of auditory canal (external)

105.5

19.6

ZXA05

NOMESCO Finland

Left side

1.4

19.4

1053

7964

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

19.1

276

1468

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

19.1

1259

9850

J01AA02

ATC

doxycycline; systemic

1.4

19.0

3159

28564

S18

ICPC

Laceration/cut

1.3

19.0

1670

13701

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

18.9

2554

22358

3890A

ICD-9 Finland

Deafness, Conductive deafness

+∞

18.8

DC1AI

NOMESCO Finland

Cone beam CT of ear

+∞

18.8

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

18.5

786

5653

3812A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media

6.5

18.5

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

18.5

371

2211

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

18.3

699

4917

3842A

ICD-9 Finland

Other disorders of tympanic membrane, Perforation of tympanic membrane

11.0

18.2

H25.8

ICD-10 Finland

Other senile cataract

1.6

17.8

463

2967

UDC10

NOMESCO Finland

Tympanoscopy

66.9

17.7

Q16.3

ICD-10 Finland

Congenital malformation of ear ossicles

180.7

17.5

H80.28

ICD-10 Finland

Cochlear otosclerosis

180.7

17.5

P20

ICPC

Memory disturbance

1.6

17.5

504

3317

R05

ICPC

Cough

1.4

17.1

803

5887

4144

FHL

Mastoidectomy or aticomastoidectomy

31.6

17.0

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

16.8

1272

10138

SPAT1312

SPAT

General health counselling

1.4

16.8

1173

9229

SPAT1310

SPAT

Counselling related to known health issue

1.4

16.7

1194

9431

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

16.6

1583

13072

H83.1

ICD-10 Finland

Labyrinthine fistula

27.6

16.5

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

16.4

1368

11063

SPAT1263

SPAT

Sampling

1.3

16.4

1599

13239

A02BC02

ATC

pantoprazole; systemic

1.3

16.4

2572

22769

SPAT1053

SPAT

Memory test

1.5

16.4

634

4464

SPAT1153

SPAT

Removal of sutures

1.3

16.2

1241

9904

H70

ICPC

Otitis externa

3.2

16.1

276

M25.5

ICD-10 Finland

Pain in joint

1.4

16.1

976

7489

4122

FHL

Tympanostomy (tympanic tube)

5.3

16.0

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

15.7

262

1471

SPAT1044

SPAT

Tympanometry

3.3

15.7

237

3892A

ICD-9 Finland

Deafness, Mixed conductive and sensorineural deafness

+∞

15.6

RK240

NOMESCO Finland

85.4

15.6

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

4.9

15.5

103

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

15.4

1437

11793

RL210

NOMESCO Finland

8.9

15.4

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

15.4

1081

8492

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

15.4

2251

19661

T16

ICD-10 Finland

Foreign body in ear

5.4

15.2

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

15.2

1019

7943

DEB00

NOMESCO Finland

Cortical mastoidectomy

56.8

14.8

R4130

NOMESCO Finland

Speech therapy

2.7

14.8

100

374

J34.2

ICD-10 Finland

Deviated nasal septum

2.1

14.7

177

880

DEB35

NOMESCO Finland

Radical mastoidectomy with tympanoplasty

+∞

14.6

Q17.2

ICD-10 Finland

Microtia

+∞

14.6

38798

ICD-8 Finland

Other disease of ear and mastoid process, Alii definiti

14.2

14.5

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

14.4

1290

10501

G44.2

ICD-10 Finland

Tension-type headache

1.6

14.4

425

2810

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

14.4

1300

10597

R51.80

ICD-10 Finland

Headache

1.5

14.3

456

3070

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

14.3

1657

13972

DFX03

NOMESCO Finland

Review, maintenance and user education for hearing aid

27.2

14.3

Q78.00

ICD-10 Finland

Congenital osteogenesis imperfecta

42.6

14.1

D33.30

ICD-10 Finland

Acoustic neuroma

8.8

13.9

M79.6

ICD-10 Finland

Pain in limb

1.3

13.9

1287

10518

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

13.7

193

1020

H69.0

ICD-10 Finland

Patulous Eustachian tube

7.3

13.7

H02AB04

ATC

methylprednisolone; systemic

1.5

13.6

535

3771

DE2DG

NOMESCO Finland

Acoustic channel very extensive MRI examination with high intensity magnet

75.3

13.6

3891A

ICD-9 Finland

Deafness, Sensorineural deafness

+∞

13.5

DDA10

NOMESCO Finland

Exploration of ossicular chain

+∞

13.5

DCB10

NOMESCO Finland

Freeing of adhesions of middle ear

+∞

13.5

R05

ICD-10 Finland

Cough

1.4

13.5

675

4987

H60.1

ICD-10 Finland

Cellulitis of external ear

4.0

13.5

134

K02.1

ICD-10 Finland

Caries of dentine

1.3

13.4

1936

16761

J01FF01

ATC

clindamycin; systemic

1.3

13.4

981

7732

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

13.3

157

775

A04

ICPC

Weakness/tiredness general

1.5

13.3

452

3090

R1260

NOMESCO Finland

Evaluation of communicative skills

3.1

13.2

225

N17

ICPC

Vertigo/dizziness

1.5

13.1

401

2673

1450

FHL

Otomicroscopy

12.2

13.1

UKC02

NOMESCO Finland

Cystoscopy

1.4

13.1

626

4586

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

13.0

525

3716

R03DC03

ATC

montelukast; oral

1.5

12.8

521

3698

R06.5

ICD-10 Finland

Mouth breathing

1.7

12.8

289

1783

H92.1

ICD-10 Finland

Otorrhoea

14.1

12.7

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

12.7

899

7041

SPAT1325

SPAT

Vaccination

1.3

12.6

1366

11368

4161

FHL

Exploratory tympanotomy

70.0

12.6

A02BC03

ATC

lansoprazole; oral

1.3

12.5

1095

8850

DDD20

NOMESCO Finland

Interposition between eardrum and footplate of stapes

+∞

12.5

3882A

ICD-9 Finland

Other disorders of ear, Sudden hearing loss, unspecified

+∞

12.5

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

12.5

1661

14192

N06AX11

ATC

mirtazapine; oral

1.3

12.5

1112

9009

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

12.5

630

4661

DCB00

NOMESCO Finland

Excision of lesion of middle ear

130.3

12.4

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

12.4

608

4473

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

12.4

831

6451

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

12.3

1837

15904

H72.1

ICD-10 Finland

Attic perforation of tympanic membrane

10.5

12.2

38299

ICD-8 Finland

Unspecified otitis media with mastoiditis

18.1

12.0

R74

ICPC

Upper respiratory infection acute

1.4

12.0

803

6227

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

11.8

1918

16748

R06AX27

ATC

desloratadine; oral

1.3

11.8

805

6258

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

11.8

329

2142

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.2

11.8

123

577

G04CA02

ATC

tamsulosin; oral

1.3

11.7

880

6946

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

4.5

11.7

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

11.6

446

3124

DC1BD

NOMESCO Finland

Temporal bone extensive CT

65.1

11.6

R06.0

ICD-10 Finland

Dyspnoea

1.3

11.6

924

7357

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

11.5

3509

32967

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

11.5

796

6203

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

11.4

811

6342

N03AX16

ATC

pregabalin; oral

1.3

11.4

835

6558

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

11.4

1948

17090

Z01.2

ICD-10 Finland

Dental examination

1.3

11.4

1355

11381

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

11.3

1374

11575

J32.4

ICD-10 Finland

Chronic pansinusitis

3.2

11.2

185

L17

ICPC

Foot/toe symptom/complaint

1.3

11.1

904

7209

R06AE07

ATC

cetirizine; oral

1.3

11.1

1499

12786

H71

ICPC

Acute otitis media/myringitis

4.0

11.0

109

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

10.9

991

8025

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

10.8

301

1964

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

10.7

1066

8736

RK510

NOMESCO Finland

12.9

10.6

N06AX16

ATC

venlafaxine; oral

1.5

10.6

403

2816

S29

ICPC

Skin symptom/complaint other

1.4

10.6

600

4525

N03AX12

ATC

gabapentin; oral

1.4

10.4

516

3798

H91.3

ICD-10 Finland

Deaf mutism, not elsewhere classified

+∞

10.4

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

10.4

1496

12826

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

10.4

422

2993

38402

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita

6.8

10.3

M03BX02

ATC

tizanidine; oral

1.2

10.3

2152

19219

J01FA09

ATC

clarithromycin; systemic

1.3

10.3

1041

8545

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

10.3

238

1478

38799

ICD-8 Finland

Other disease of ear and mastoid process, Other

23.4

10.2

WZA90

NOMESCO Finland

Other doctors statement

1.3

10.2

740

5802

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

10.2

581

4384

4146

FHL

Radical cutting (bridge broken)

40.1

10.0

L08

ICPC

Shoulder symptom/complaint

1.3

9.9

660

5099

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

9.9

269

1743

WX722

NOMESCO Finland

PEEP

1.8

9.9

172

982

H61.8

ICD-10 Finland

Other specified disorders of external ear

3.3

9.9

142

L12

ICPC

Hand/finger symptom/complaint

1.4

9.8

464

3383

Z96.2

ICD-10 Finland

Presence of otological and audiological implants

26.1

9.8

4139

FHL

Other measure in this category

20.1

9.8

UDM02

NOMESCO Finland

Sinoscopy

2.4

9.7

320

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

9.7

921

7491

R5599

NOMESCO Finland

Other rehabilitation service

2.2

9.7

411

L15

ICPC

Knee symptom/complaint

1.3

9.6

714

5610

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

9.6

365

2554

C07AB07

ATC

bisoprolol; oral

1.2

9.6

1895

16778

L28

ICPC

Limited function/disability (L)

1.4

9.6

581

4425

SPAT1260

SPAT

Consultation of another employee

1.3

9.5

628

4846

DJD20

NOMESCO Finland

Plastic repair of septum of nose

2.0

9.5

116

586

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

9.5

230

1450

J45

ICD-10 Finland

Asthma

1.5

9.5

306

2066

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

9.5

536

4036

D07AC01

ATC

betamethasone; topical

1.3

9.4

1199

10110

Q35.1

ICD-10 Finland

Cleft hard palate

21.7

9.3

-1

NOMESCO Finland

1.3

9.3

1043

8657

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

878

4686

2.06

73.92

2.2

1.8

—

(3013707) Erythrocyte sedimentation rate by Westergren method

3466

29727

1.54

41.16

4.6

4.1

mm/h

13.5

13.6

0.07

3158

27274

(3019550) Sodium [Moles/volume] in Serum or Plasma

4523

41569

1.90

39.66

20.4

18.2

mmol/l

139.7

139.6

1.13

4408

40487

(3023103) Potassium [Moles/volume] in Serum or Plasma

4528

41661

1.90

39.10

20.5

18.4

mmol/l

4.0

0.44

4408

40506

(3000494) Fungus identified in Specimen by Culture

750

4623

1.73

38.14

1.7

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4554

42154

1.88

36.01

11.9

10.9

u/l

24.9

25.7

2.36

4334

40495

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4105

36972

1.61

35.61

6.7

6.1

mmol/mol

40.5

40.3

0.75

3704

33882

(3037467) Urinalysis macro (dipstick) panel - Urine

3259

27998

1.47

34.95

5.2

4.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4042

36357

1.58

34.32

5.2

4.8

mu/l

2.0

2.1

0.93

3613

32881

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4549

42202

1.85

34.15

20.2

18.4

umol/l

80.5

79.4

1.14

4549

42186

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4342

39782

1.68

33.74

17.4

15.6

mg/l

24.6

25.6

1.03

3569

31933

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4252

38787

1.64

33.17

5.2

4.8

mmol/l

6.0

0.28

3776

34935

(3013512) EKG study

1608

12179

1.47

33.06

4.3

4.1

—

(3007461) Platelets [#/volume] in Blood

4665

43722

1.97

32.56

25.9

22.9

e9/l

246.6

247.7

0.51

4543

42439

(3010813) Leukocytes [#/volume] in Blood

4667

43748

1.97

32.54

25.9

22.9

e9/l

6.9

6.8

0.74

4525

42287

(3024731) MCV [Entitic volume]

4665

43734

1.97

32.34

25.8

22.8

91.2

91.4

2.29

4586

43004

(3035941) MCH [Entitic mass]

4665

43735

1.97

32.33

25.7

22.8

30.3

30.4

1.10

4586

43003

(3026361) Erythrocytes [#/volume] in Blood

4665

43738

1.96

32.27

25.9

22.9

e12/l

4.4

0.26

4528

42279

(3000963) Hemoglobin [Mass/volume] in Blood

4665

43751

1.96

32.05

26.0

23.0

g/l

133.5

133.9

0.97

4584

43032

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2192

17668

1.43

32.00

2.1

2.0

pmol/l

98.0

93.9

2.96

1126

9039

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3595

31823

1.46

30.30

7.9

7.7

u/l

78.6

80.0

1.02

3352

29875

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

757

5015

1.60

28.46

5.0

4.7

33.9

32.9

1.74

498

3259

(40761511) CBC panel - Blood by Automated count

4413

40947

1.65

28.45

16.9

14.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1139

8294

1.48

27.67

1.7

1.8

nmol/l

1137.7

1176.0

0.67

816

6219

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4296

39769

1.56

26.06

5.5

5.1

mmol/l

2.7

1.02

3867

36220

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2335

19487

1.37

25.64

6.4

6.1

mmol/l

1.2

2.68

2064

17584

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4202

38815

1.51

24.65

4.9

4.5

mmol/l

4.6

1.62

3782

35529

(3019225) pH of Specimen

647

4264

1.59

24.62

4.3

4.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1956

16006

1.36

23.69

4.2

3.8

ng/l

39.9

89.4

1.02

1424

11639

(42870588) Differential panel, method unspecified - Blood

1732

13983

1.36

22.55

6.4

5.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4158

38487

1.47

22.55

4.9

4.5

mmol/l

1.5

1.32

3721

34997

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3363

30076

1.36

21.88

4.2

4.0

pmol/l

15.0

14.9

1.07

2992

27064

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2511

21513

1.34

21.76

7.2

6.8

mmol/l

1.2

3.41

2112

18073

(3013826) Glucose [Moles/volume] in Serum or Plasma

2822

24617

1.34

21.48

5.0

4.7

mmol/l

6.9

6.8

1.10

2654

23062

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4027

37162

1.43

21.16

4.3

4.1

mmol/l

1.3

0.39

3581

33483

(3031040) Bacteria [#/volume] in Urine by Automated count

3079

27237

1.34

21.12

5.2

4.7

e6/l

670.2

2167.4

1.34

413

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1593

12863

1.35

20.16

2.7

2.6

u/l

57.4

57.9

0.11

1456

11812

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2517

21833

1.31

18.79

6.1

6.3

umol/l

11.4

11.7

0.60

2372

20711

(3013115) Eosinophils [#/volume] in Blood

2410

20792

1.31

18.69

6.5

6.0

e9/l

0.2

0.18

2102

17963

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1589

13016

1.32

17.69

3.2

3.1

ng/l

1520.6

1628.5

0.47

1350

11286

(3032080) INR in Blood by Coagulation assay

2074

17636

1.30

17.51

9.9

9.8

inr

1.3

0.64

544

4921

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1979

16754

1.30

17.17

2.4

2.2

nmol/l

78.7

78.6

0.05

1730

14844

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

715

5179

1.44

16.97

8.7

7.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1342

10783

1.33

16.94

2.4

2.3

mg/l

3.0

0.19

1109

9188

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

279

1633

1.75

16.63

4.1

mmol/l

24.9

0.04

256

1487

(3019069) Monocytes/100 leukocytes in Blood

2208

19017

1.29

16.58

7.2

6.3

8.8

0.23

2044

17658

(3006504) Eosinophils/100 leukocytes in Blood

2198

18922

1.29

16.56

6.8

6.0

2.9

0.07

2023

17500

(3006315) Basophils [#/volume] in Blood

2323

20156

1.28

16.39

6.4

5.8

e9/l

0.0

1.02

2026

17132

(3042936) Bacteria identified in Isolate by Culture

796

5913

1.41

16.39

2.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1667

13868

1.30

16.25

5.3

5.2

ug/l

2.8

3.6

1.32

1449

12318

(3002030) Lymphocytes/100 leukocytes in Blood

2247

19435

1.28

16.18

7.0

6.1

27.1

27.0

0.09

2067

17944

(3020682) Albumin/Creatinine [Ratio] in Urine

1631

13537

1.30

16.15

4.2

3.9

mg/mmol

8.1

9.3

0.46

965

8541

(3018010) Neutrophils/100 leukocytes in Blood

2216

19154

1.28

15.96

6.7

5.9

57.5

57.9

0.77

2052

17770

(3022313) Gas panel - Capillary blood

311

1900

1.68

15.87

3.9

4.0

—

(3019198) Lymphocytes [#/volume] in Blood

2361

20579

1.28

15.86

6.4

5.8

e9/l

1.9

0.19

2083

17818

(3001604) Monocytes [#/volume] in Blood

2305

20046

1.28

15.71

6.3

5.8

e9/l

0.6

0.63

2010

17031

(3015736) pH of Urine

1810

15313

1.28

15.25

4.0

3.5

—

5.8

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1937

16528

1.28

15.24

3.0

2.9

ug/l

150.9

140.0

0.61

1744

15170

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

918

7080

1.36

14.94

2.0

1.8

—

(3009508) Creatinine [Moles/volume] in Urine

1599

13367

1.29

14.65

3.4

3.2

mmol/l

7.1

7.3

1.37

1319

11125

(3021960) Folate [Moles/volume] in Serum or Plasma

1247

10129

1.31

14.11

1.6

nmol/l

21.0

20.2

0.86

1036

8630

(3022096) Basophils/100 leukocytes in Blood

2115

18391

1.26

13.77

6.9

6.0

0.7

3.17

1953

17032

(3023368) Bacteria identified in Blood by Culture

1446

12086

1.28

12.91

4.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2120

18550

1.25

12.73

5.0

4.9

g/l

35.0

0.17

1940

17150

(3012516) Albumin [Mass/volume] in Urine

1524

12863

1.27

12.45

3.5

3.2

mg/l

695.7

321.5

1.46

907

8153

(3019150) Specific gravity of Urine by Refractometry

1063

8590

1.30

12.25

4.5

4.3

kg/l

1.0

0.01

129

1359

(3026008) Bacteria identified in Urine by Culture

1570

13321

1.26

12.22

3.5

3.3

—

(3009261) Glucose [Presence] in Urine by Test strip

2252

19910

1.24

12.08

4.4

3.8

estimate

0.0

0.50

342

3577

(3035350) Ketones [Presence] in Urine by Test strip

2221

19612

1.24

12.03

4.3

3.8

estimate

0.0

0.00

340

3626

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1109

9031

1.29

12.03

1.7

pmol/l

20753013.2

26408411.7

0.18

877

7422

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

390

2684

1.49

11.92

4.0

3.8

kpa

5.2

0.73

361

2475

(3013650) Neutrophils [#/volume] in Blood by Automated count

2615

23515

1.23

11.88

9.2

e9/l

4.2

0.11

2316

20314

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

817

6398

1.33

11.76

1.3

iu/ml

35.5

35.9

0.02

269

1993

(3021601) Nitrite [Presence] in Urine by Test strip

2224

19674

1.23

11.74

5.9

5.1

estimate

0.0

0.80

344

3669

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

109

529

2.08

11.58

1.4

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3980

37558

1.29

11.56

15.6

14.9

ml/min/173m2

76.9

77.2

0.37

3268

31011

(3009343) pH of Capillary blood

384

2651

1.49

11.56

4.0

3.8

7.4

0.39

335

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2734

24748

1.23

11.49

3.3

3.1

u/l

54.2

52.0

0.43

2498

22708

(3024522) Salmonella sp identified in Specimen by Organism specific culture

108

525

2.08

11.43

1.4

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

107

520

2.08

11.33

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

106

522

2.05

10.85

1.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1505

12855

1.24

10.74

2.3

2.1

u/l

172.6

204.3

1.34

1382

12006

(3009542) Hematocrit [Volume Fraction] of Blood

3755

35278

1.26

10.73

18.6

17.0

38.9

39.2

0.89

2330

23998

(3025468) Yersinia sp identified in Specimen by Organism specific culture

105

520

2.04

10.60

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

367

2555

1.47

10.59

4.1

3.7

mmol/l

1.7

1.9

0.61

291

1912

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

105

521

2.04

10.55

1.5

—

(3047181) Lactate [Moles/volume] in Blood

216

1338

1.64

10.52

5.4

6.3

mmol/l

1.5

1.3

1.33

200

1177

(3007164) IgA [Mass/volume] in Serum or Plasma

876

7053

1.29

10.18

1.4

1.5

g/l

2.5

0.03

494

4102

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2402

21620

1.21

10.11

2.7

2.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

974

7988

1.27

9.74

1.3

u/ml

1.9

1.7

0.16

230

2034

(4010399)

395

2837

1.43

9.67

1.6

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

388

2779

1.43

9.64

6.8

7.0

mmol/l

24.7

0.00

365

2582

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1700

14858

1.22

9.46

4.7

4.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

138

780

1.79

9.41

1.7

1.2

titre

60.0

256.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1263

10718

1.24

9.32

1.7

1.6

mmol/l

1.4

0.24

1040

8934

(3026493) Urate [Moles/volume] in Serum or Plasma

1274

10832

1.24

9.22

3.0

2.8

umol/l

4380.5

5457.8

0.41

1085

9240

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

327

2291

1.46

9.15

2.5

2.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

268

1812

1.51

8.96

4.9

5.2

1.7

1.6

0.27

255

1688

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

498

1.97

8.92

2.1

mg/l

29.5

26.0

0.20

126

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

751

6023

1.29

8.91

1.3

1.2

u/ml

11.2

13.6

0.49

283

2220

(40761535) Cells panel - Urine sediment

463

3465

1.37

8.89

3.8

3.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

265

1793

1.50

8.84

2.1

2.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

154

918

1.70

8.74

1.5

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

248

1660

1.52

8.71

1.9

1.8

—

(3017732) Neutrophils [#/volume] in Blood

367

2654

1.41

8.65

2.6

3.2

e9/l

4.1

4.2

0.24

253

1992

(3007930) Methemoglobin/Hemoglobin.total in Blood

264

1799

1.49

8.52

4.9

5.2

0.9

1.46

251

1682

(3037522) Nuclear Ab [Titer] in Serum

632

4989

1.31

8.44

1.4

1.3

titre

507.6

497.1

0.05

139

1076

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1296

11134

1.22

8.35

4.8

4.5

22.4

22.1

0.34

661

5736

(3005719) IgG [Mass/volume] in Serum or Plasma

397

2933

1.38

8.26

3.3

2.7

g/l

10.3

10.5

0.43

364

2680

(3011397) Hemoglobin [Presence] in Urine by Test strip

1126

9571

1.23

8.01

4.2

3.7

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

142

2.76

7.95

1.1

u/ml

1.7

7.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

213

1409

1.53

7.93

2.9

2.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

422

3172

1.36

7.89

1.8

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1193

10214

1.22

7.89

2.8

2.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

618

4918

1.29

7.75

1.9

1.7

—

(3039000) Anion gap in Blood

157

973

1.63

7.72

6.1

7.1

mmol/l

11.1

0.03

144

865

(40768804) Tissue Pathology biopsy report

1848

16509

1.19

7.71

2.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1641

14508

1.19

7.70

3.1

3.5

mmol/l

2.4

0.31

1368

12553

(3018572) Chloride [Moles/volume] in Blood

157

974

1.63

7.69

6.1

7.1

mmol/l

105.6

105.1

0.47

144

866

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

205

1361

1.53

7.52

2.2

1.6

titre

206.0

359.3

—

(3048689) Calprotectin [Mass/mass] in Stool

547

4315

1.30

7.32

2.0

2.2

ug/g

149.2

148.6

0.01

407

3337

(3044640) Blood type and Crossmatch panel - Blood

1516

13367

1.19

7.23

2.8

2.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2120

19285

1.17

6.88

4.6

4.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

249

1753

1.44

6.86

2.3

1.6

u/ml

6.4

22.4

2.23

(36660697) Celiac disease serology panel - Serum

381

2882

1.35

6.85

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

609

4913

1.27

6.83

1.9

1.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

647

5287

1.26

6.51

1.5

1.4

—

(40768797) Stomach Pathology biopsy report

678

5600

1.24

6.20

1.3

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

289

2135

1.38

6.07

1.4

1.3

u/ml

185.4

230.5

0.83

268

1949

(4034850)

187

1278

1.48

6.04

11.5

10.1

—

(3029937) Albumin [Presence] in Urine by Test strip

1212

10620

1.19

6.02

4.7

4.2

estimate

0.0

1.34

337

3526

(3023520) Reticulocytes [#/volume] in Blood

484

3855

1.28

6.02

2.8

2.5

e9/l

70.4

69.8

0.12

376

2860

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

426

3349

1.30

5.86

3.9

3.8

ng/l

99.1

93.1

0.51

353

2848

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

493

3976

1.27

5.54

2.9

2.8

ng/l

182.0

214.4

1.18

451

3629

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

300

2268

1.34

5.46

1.3

au/ml

40.0

51.5

0.37

100

(3019060) Gas panel - Arterial blood

380

2973

1.30

5.44

5.0

4.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

201

1424

1.43

5.42

1.3

1.2

u/ml

0.2

0.9

1.73

133

(3044889) 12 lead EKG panel

3050

28804

1.15

5.40

4.3

4.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

303

2303

1.34

5.33

1.9

g/l

1.2

1.4

0.58

269

2084

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

395

1.81

5.28

1.1

—

2.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

162

1115

1.47

5.11

1.7

1.6

iu/ml

0.1

8.4

0.86

243

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1000

8735

1.18

5.06

1.7

mg/l

1.3

1.4

0.18

774

6759

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

260

1956

1.35

4.92

3.6

2.7

0.7

1.06

249

1877

(3003458) Phosphate [Moles/volume] in Serum or Plasma

678

5735

1.21

4.90

6.1

5.9

mmol/l

1.0

0.39

620

5292

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

249

1.98

4.82

2.2

2.4

e6/l

749.6

611.4

0.58

102

(3004616) Nuclear Ab [Presence] in Serum

453

1.71

4.77

1.4

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

321

2513

1.30

4.61

2.4

au/ml

13.0

22.0

1.30

116

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

605

5097

1.21

4.56

4.1

4.2

u/l

245.2

245.9

0.05

553

4794

(3004119) Hemoglobin [Mass/volume] in Venous blood

334

2634

1.29

4.54

3.9

3.3

g/l

126.8

128.0

0.47

329

2565

(3008757) Leukocyte morphology finding [Identifier] in Blood

453

1.69

4.51

3.7

4.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

516

1.64

4.45

1.4

1.6

59.4

60.1

0.05

323

(3020891) Body temperature

232

1744

1.35

4.45

5.6

4.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

184

1333

1.39

4.44

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

137

942

1.47

4.40

1.3

mg/l

490.2

535.5

0.69

129

891

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

196

2.05

4.37

2.5

2.4

—

(4146454)

488

1.65

4.36

2.6

2.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

443

1.68

4.33

3.5

3.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

604

5114

1.21

4.32

2.7

2.5

1.8

0.49

510

4509

(3025941) Bacteria identified in Stool by Culture

271

2094

1.31

4.31

1.3

—

(4015189)

107

2.44

4.29

2.8

2.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

570

1.59

4.23

1.9

1.6

—

(3023419) Bacteria identified in Sputum by Culture

532

1.61

4.20

3.2

2.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

241

1839

1.33

4.19

2.1

1.9

ug/l

1.2

2.7

2.30

207

1618

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.99

4.12

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

122

832

1.48

4.11

1.2

1.3

mmol/l

3.9

3.8

0.54

112

781

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

335

2683

1.27

4.05

1.8

1.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

121

827

1.47

4.04

1.4

e6/l

324.1

1253.1

1.74

105

667

(3016502) Oxygen saturation in Arterial blood

550

4652

1.20

3.98

6.7

7.3

95.5

0.08

525

4473

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

156

1121

1.40

3.98

1.8

1.4

iu/ml

11.7

16.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

776

6766

1.17

3.97

2.6

umol/l

12.2

12.5

0.47

709

6253

(4062490)

348

1.73

3.97

1.4

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

439

1.65

3.97

4.4

3.7

60.2

58.0

0.37

268

(3037121) Protein [Mass/volume] in Urine

197

1472

1.35

3.97

3.2

3.1

g/l

0.3

0.07

613

(3022217) INR in Platelet poor plasma by Coagulation assay

708

6131

1.18

3.94

31.1

26.4

inr

1.3

1.4

1.18

104

881

(3044290) Cell count panel - Cerebral spinal fluid

113

766

1.49

3.94

1.3

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

349

1.73

3.93

1.3

g/l

3.0

2.9

0.08

244

(3024139) IgG subclass 3 [Mass/volume] in Serum

349

1.73

3.93

1.3

g/l

0.4

0.04

244

(3027135) IgG subclass 1 [Mass/volume] in Serum

349

1.73

3.93

1.3

g/l

7.0

6.9

0.05

244

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

262

1.84

3.89

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

338

1.72

3.79

1.2

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

209

1.92

3.71

11.3

13.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

582

1.54

3.69

1.5

1.6

g/l

0.7

0.8

0.59

441

(3048879) Bone marrow aspiration report

122

2.22

3.66

1.9

1.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

123

865

1.43

3.58

1.4

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

292

1.75

3.56

1.3

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

141

1017

1.40

3.56

2.0

1.9

mg/l

13.6

11.5

0.58

128

943

(3018418) pH of Serum or Plasma

1411

12921

1.13

3.55

4.5

4.1

7.4

0.09

230

2451

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

118

826

1.44

3.53

1.3

1.4

e6/l

121.5

25.9

0.47

630

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

182

1371

1.34

3.51

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

541

1.54

3.51

2.2

2.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

243

1.82

3.47

1.4

1.3

u/ml

0.7

1.3

0.33

113

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

222

1.85

3.44

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

222

1.85

3.44

1.3

1.4

—

(3003396) Base excess in Arterial blood by calculation

602

5202

1.18

3.44

6.6

6.9

mmol/l

1.4

1.1

1.11

463

4057

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

288

1.74

3.44

1.3

1.4

—

(3044927) Protein electrophoresis panel - Urine

451

1.58

3.37

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

119

842

1.42

3.37

1.2

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

224

1.84

3.36

1.6

2.4

umol/l

21.3

26.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

603

5227

1.17

3.32

6.6

6.9

kpa

11.8

12.2

1.66

573

4959

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

463

3924

1.20

3.31

2.4

2.3

ug/l

6.9

7.3

0.14

367

3398

(3000475) Leukocytes [#/volume] in Synovial fluid

142

1040

1.38

3.30

1.5

1.6

e6/l

12122.6

13106.0

0.07

106

730

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

138

1006

1.38

3.30

1.8

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

603

5230

1.17

3.30

6.6

6.9

kpa

5.1

0.12

574

4962

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

134

973

1.39

3.29

1.8

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

384

1.62

3.28

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

640

1.48

3.27

2.6

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.74

3.23

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

210

1636

1.30

3.22

1.9

1.8

u/l

38.7

39.0

0.09

182

1421

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

195

1505

1.31

3.21

1.9

2.2

ug/l

282.8

520.2

2.88

178

1421

(3004789) Transferrin [Mass/volume] in Serum or Plasma

711

6263

1.16

3.19

2.6

2.5

g/l

2.3

1.86

650

5791

(3035285) Chloride [Moles/volume] in Venous blood

554

1.51

3.19

2.2

2.4

mmol/l

104.9

105.3

0.28

547

(3041354) Potassium [Moles/volume] in Venous blood

554

1.51

3.19

2.2

2.4

mmol/l

4.1

0.12

547

(3002173) Hemoglobin [Mass/volume] in Arterial blood

499

4274

1.19

3.18

7.1

7.6

g/l

120.7

120.3

0.17

477

4112

(40768443) Skin Pathology biopsy report

228

1800

1.28

3.16

1.1

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

154

1155

1.34

3.10

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

949

8546

1.14

3.09

4.0

3.9

ng/l

440.5

498.7

0.12

766

7012

(3000093) Morphology [Interpretation] in Blood Narrative

406

1.58

3.09

1.2

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

246

1.75

3.06

1.9

2.4

e6/l

456.7

490.4

0.23

207

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

139

2.02

3.05

1.9

2.0

ug/l

64.3

55.8

0.15

134

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.01

3.05

1.4

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

668

5878

1.16

3.04

2.7

2.6

20.9

22.0

1.17

544

5016

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

361

1.61

3.03

1.8

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

361

1.61

3.03

1.8

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

361

1.61

3.03

1.8

1.6

—

(3003338) MCHC [Mass/volume]

3406

32907

1.11

2.95

23.2

20.3

g/l

331.7

0.04

3385

32600

(3014271) Vancomycin [Susceptibility]

234

1.76

2.95

3.3

3.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.47

2.95

1.2

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

141

1053

1.35

2.94

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

104

739

1.42

2.93

1.9

1.6

—

(21494815) CD4 cells/100 lymphocytes in Specimen

318

1.64

2.92

2.1

2.3

38.3

39.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

296

1.66

2.89

1.0

ng/l

707.2

695.7

0.07

195

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

297

2454

1.22

2.80

8.1

9.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

299

1.65

2.79

1.0

ng/l

42.5

44.1

0.11

199

(3000034) Microalbumin [Mass/volume] in Urine

394

1.55

2.76

2.7

3.0

mg/l

46.2

36.1

0.21

296

(3024932) HLA-DR beta [Type]

2.15

2.70

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

341

1.59

2.70

1.9

1.6

u/ml

29.1

22.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

602

1.44

2.66

5.4

6.4

mg/l

10.9

12.0

1.51

548

(3008898) HLA-B27 [Presence]

138

1046

1.33

2.64

1.0

1.1

—

(3022145) Colonoscopy Study observation

509

4438

1.16

2.64

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

147

1125

1.32

2.63

1.9

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

213

1.74

2.62

2.0

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

213

1.74

2.62

2.0

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

213

1.74

2.62

2.0

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

213

1.74

2.62

2.0

1.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

257

2108

1.23

2.62

1.7

g/l

1.6

0.23

207

1812

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

297

1.62

2.61

1.0

ng/l

339.4

317.8

0.23

201

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

469

4084

1.16

2.48

2.2

g/l

0.2

0.10

430

3787

(3042733) HLA Ab [Presence] in Serum

2.11

2.48

6.1

5.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

579

5121

1.15

2.48

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

266

2204

1.22

2.47

3.1

2.8

e6/l

0.3

0.29

259

2159

(3004809) Band form neutrophils/100 leukocytes in Blood

721

1.38

2.47

4.6

3.6

1.5

0.05

544

(3024471) HLA-A [Type]

102

2.06

2.46

1.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

170

1340

1.28

2.46

4.5

4.3

mmol/l

3.9

0.12

164

1253

(3011412) CD3 cells [#/volume] in Blood

374

1.53

2.45

2.1

2.3

e9/l

1.1

0.04

237

(3014576) Chloride [Moles/volume] in Serum or Plasma

625

5563

1.14

2.44

6.9

6.8

mmol/l

104.3

104.4

0.33

607

5441

(3013139) Helicobacter pylori Ag [Presence] in Stool

311

2621

1.20

2.43

1.3

1.2

—

(3002032) Base excess in Venous blood by calculation

475

4150

1.16

2.41

4.5

3.8

mmol/l

1.9

2.0

0.02

376

3378

(3008401) Mugwort IgE Ab [Units/volume] in Serum

424

1.49

2.41

1.0

1.1

u/ml

0.2

1.2

2.70

185

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

167

1.80

2.40

2.1

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

167

1.80

2.40

2.1

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

167

1.80

2.40

2.1

2.0

—

(3012544) pH of Venous blood

490

4294

1.16

2.39

4.6

3.8

—

7.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

168

1.79

2.36

1.3

—

(3025130) Human papilloma virus identified in Specimen

410

1.49

2.35

1.4

1.7

—

(40758558) Short blood count panel - Blood

1143

10563

1.11

2.34

7.0

6.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

142

1104

1.29

2.31

4.4

3.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

105

2.00

2.30

2.2

2.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1375

12839

1.10

2.28

3.6

3.3

u/l

30.3

36.5

3.20

1303

12099

(3034274) Bile acid [Moles/volume] in Serum --fasting

270

1.60

2.25

1.4

1.8

umol/l

4.5

7.0

1.23

187

(3012095) Magnesium [Moles/volume] in Serum or Plasma

788

7156

1.12

2.23

3.5

3.3

mmol/l

0.8

0.07

717

6652

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

114

1.93

2.20

1.1

1.3

40.0

33.5

0.30

(3004588) Protein electrophoresis panel - Serum or Plasma

364

3142

1.17

2.18

2.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.24

2.17

1.2

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

456

4008

1.15

2.16

1.6

—

(3037756) Immunofixation for Serum or Plasma

127

984

1.30

2.14

1.7

1.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.37

2.12

1.1

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

116

1.90

2.10

1.3

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

2.00

2.10

2.1

2.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

296

2521

1.19

2.10

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

471

1.43

2.10

1.8

1.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.26

2.07

1.4

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.91

2.07

1.1

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

582

1.38

2.07

1.7

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

415

1.45

2.05

2.0

1.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

450

1.43

2.01

1.2

u/l

50.3

61.4

1.42

304

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.50

2.01

1.1

46.0

51.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.63

2.01

1.1

1.0

—

(3042631) Mycobacterium sp identified in Specimen

586

1.37

1.99

3.8

2.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

432

3807

1.15

1.99

2.7

2.6

g/l

65.2

66.2

1.64

382

3432

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

511

1.40

1.97

1.1

u/ml

3.7

1.8

0.24

209

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

322

1.50

1.93

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

573

1.37

1.92

1.5

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

306

1.51

1.92

1.0

1.1

u/ml

1.9

2.9

0.62

128

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

135

1072

1.27

1.92

1.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

722

1.32

1.88

1.5

1.4

—

(4027681)

197

1.63

1.86

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

441

1.41

1.85

1.0

u/ml

0.8

4.4

5.28

228

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

391

1.44

1.85

1.7

titre

1053.3

1243.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

143

1151

1.25

1.82

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

451

1.40

1.82

2.0

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

116

911

1.28

1.82

4.3

3.6

mg/l

31.0

28.2

0.31

584

(3021447) Carbon dioxide [Partial pressure] in Venous blood

466

4156

1.13

1.81

4.6

3.8

kpa

5.9

5.8

0.87

458

4025

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

368

1.44

1.81

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

136

1090

1.25

1.80

1.3

1.4

iu/l

32.8

31.8

0.12

116

925

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

176

1451

1.22

1.80

3.9

3.2

ratio

5.7

3.6

0.22

114

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

142

1144

1.25

1.80

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

910

8423

1.10

1.80

5.2

4.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

352

1.45

1.80

1.5

1.1

u/ml

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

336

1.46

1.79

2.3

2.4

—

(3021788) Differential panel - Synovial fluid

101

781

1.30

1.78

1.5

—

(3044941) Cell count panel - Synovial fluid

694

1.32

1.78

1.3

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

180

1491

1.21

1.77

3.9

3.3

mg/l

42.5

51.4

0.35

146

1227

(3041096) Erythrocytes [Presence] in Urine by Automated

1096

10240

1.09

1.76

4.2

3.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

143

1158

1.24

1.74

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

110

1.82

1.72

1.2

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

139

1124

1.24

1.72

6.7

4.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

516

1.36

1.72

1.5

1.4

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

3.85

1.71

1.0

—

(3028433) Virus identified in Specimen by Culture

133

1.73

1.69

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

216

2540

0.84

1.69

1.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

426

3803

1.13

1.65

1.6

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

179

1494

1.21

1.65

3.9

3.3

mg/l

85.6

94.6

0.07

145

1233

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

491

4425

1.12

1.63

1.6

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

137

1114

1.24

1.63

1.6

1.5

g/l

0.2

0.22

131

1056

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

526

4761

1.12

1.62

2.7

umol/l

7.0

8.8

1.76

452

4116

(3024354) Oxygen [Partial pressure] in Venous blood

382

3393

1.14

1.61

4.1

3.2

kpa

4.3

4.5

1.49

371

3272

(3000060) B lymphocytes [#/volume] in Blood

1.87

1.60

1.6

2.4

e6/l

185.0

150.0

0.28

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

116

929

1.25

1.59

1.3

1.2

u/ml

4.1

3.4

0.13

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

117

938

1.25

1.59

1.4

1.3

u/ml

3.2

7.1

1.41

137

(3027456) Digoxin [Moles/volume] in Serum or Plasma

121

975

1.25

1.57

3.2

3.1

nmol/l

0.8

0.40

743

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.20

1.56

2.3

2.5

—

39.7

—

(3006653) Thiamine [Moles/volume] in Blood

192

1.57

1.53

1.4

1.2

nmol/l

144.5

136.9

0.43

192

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.86

1.50

1.7

1.6

mg/l

0.1

0.3

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.86

1.50

1.7

1.6

mg/l

0.4

0.5

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.86

1.50

1.7

1.6

mg/l

0.7

0.6

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.86

1.50

1.7

1.6

mg/l

2.5

2.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

573

5235

1.11

1.50

1.3

1.4

—

(3027944) Amphetamines [Presence] in Urine

740

1.28

1.50

1.9

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

292

1.44

1.48

2.1

2.2

15.8

14.0

0.29

122

(3006270) Folate [Moles/volume] in Blood

376

1.39

1.47

1.2

nmol/l

320.1

365.5

0.82

307

(3017704) Immunofixation for Urine

243

1.48

1.46

1.9

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

243

1.48

1.46

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.22

1.46

1.5

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

245

2129

1.16

1.44

1.8

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

404

1.37

1.43

1.3

1.4

e6/l

104946.4

93049.1

0.04

271

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

212

1.51

1.43

1.2

1.1

u/l

63.1

89.7

1.59

156

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.79

1.42

1.5

1.6

ug/l

8.6

9.1

0.26

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

648

1.29

1.42

1.5

1.3

—

(3010503) CD19 cells [#/volume] in Blood

245

1.47

1.42

2.4

2.3

e9/l

0.1

0.2

0.80

234

(3016879) Cocaine [Presence] in Urine

702

1.27

1.41

1.9

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

139

1153

1.21

1.41

1.5

g/l

1.2

0.14

134

1093

(3000764) Benzodiazepines [Presence] in Urine

756

1.26

1.40

1.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

137

1135

1.21

1.40

1.7

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

213

1.51

1.40

1.2

1.1

u/l

17.7

31.7

1.74

153

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

213

1.51

1.40

3.7

2.7

39.5

37.2

0.23

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

165

1.58

1.40

1.2

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.18

1.39

1.9

2.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

127

1045

1.22

1.39

1.2

titre

74.3

97.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

111

1.71

1.38

2.2

1.5

ug/l

0.3

0.4

1.35

(3027008) Opiates [Presence] in Urine

758

1.26

1.38

1.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

407

1.36

1.37

1.1

1.0

u/ml

2.1

2.0

—

(3049717) Cytology report of Urine Cyto stain

207

1784

1.17

1.37

2.8

2.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

174

1.55

1.37

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

104

1.73

1.36

1.0

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

264

1.44

1.36

1.2

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

281

1.43

1.35

1.3

1.2

u/ml

2.4

3.7

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

159

1.58

1.34

2.6

2.1

umol/l

52.7

55.7

0.15

124

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

290

1.42

1.34

1.5

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.14

1.33

1.8

3.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.14

1.33

1.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

364

3268

1.12

1.33

2.8

2.6

ml/min/173m2

63.3

63.2

0.01

149

1298

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

105

1.72

1.33

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

864

8092

1.08

1.32

3.2

3.1

ug/l

0.7

0.8

0.79

614

5687

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

350

1.38

1.32

1.6

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

199

1716

1.17

1.32

1.4

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

799

1.24

1.31

5.8

4.6

iu/ml

371.4

2642.2

0.55

106

(3028300) Cannabinoids [Presence] in Urine

764

1.25

1.30

1.9

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

393

3549

1.12

1.30

2.3

2.2

nmol/l

367.9

377.4

0.43

351

3250

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

121

1.66

1.30

1.2

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

2.50

1.30

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

439

0.68

1.30

1.0

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

693

1.26

1.30

1.3

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.78

1.28

1.2

2.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

121

1001

1.21

1.28

1.3

1.2

u/ml

4.0

34.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

456

1.32

1.28

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

500

1.30

1.27

4.1

20.2

mmol/l

7.4

0.01

422

(3016018) Differential panel - Cerebral spinal fluid

396

1.34

1.27

1.5

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

726

6765

1.09

1.26

2.0

29.5

29.9

1.04

693

6578

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

732

1.25

1.26

1.5

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

261

1.42

1.24

1.1

1.2

mg/l

35.8

42.8

0.88

219

(3009466) Valproate [Moles/volume] in Serum or Plasma

529

1.29

1.23

3.8

4.8

umol/l

390.4

353.5

1.17

453

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

270

1.41

1.23

1.5

u/l

4.1

6.7

0.63

128

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.00

1.23

2.6

2.5

mg/l

1.1

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

267

2366

1.14

1.23

1.9

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

364

1.35

1.22

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

583

1.27

1.22

1.5

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.04

1.22

1.9

2.1

—

(3002619) Bacteria identified in Specimen by Culture

1.75

1.18

1.1

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

189

1.48

1.18

1.4

1.5

—

(44813793)

231

1.43

1.17

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.00

1.16

1.5

1.6

—

(3051651) Icteric interference index of Serum or Plasma

265

1.40

1.16

3.1

3.4

—

(3002385) Erythrocyte distribution width [Ratio]

3324

32594

1.06

1.15

20.6

19.2

13.8

0.00

3252

31831

(3003740) Influenza virus B Ag [Presence] in Specimen

439

0.70

1.15

1.0

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

216

1.44

1.13

6.2

3.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

119

1413

0.84

1.13

1.6

1.7

—

(4035726)

360

3961

0.90

1.13

1.4

—

(3003694) ABO and Rh group [Type] in Blood

1009

10633

0.94

1.12

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

327

1.35

1.12

2.0

1.4

—

(3002256) Pathology report gross observation

590

5486

1.09

1.10

1.3

—

(3025315) Body weight

2.26

1.10

4.9

5.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

251

1.40

1.10

1.6

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

486

1.28

1.09

1.9

2.0

—

(3042517) Benzodiazepines panel - Urine

2.38

1.09

4.0

1.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

104

1.64

1.09

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

144

1.53

1.08

1.1

1.3

—

(44806420)

136

1.55

1.08

2.7

2.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

111

930

1.20

1.07

1.1

u/ml

19.2

5.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

105

1.62

1.05

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

686

1.23

1.05

1.4

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

203

1.43

1.05

3.2

3.0

—

(3020779) Urea [Moles/volume] in Serum or Plasma

440

4053

1.09

1.03

7.2

7.1

mmol/l

11.0

10.4

0.79

420

3852

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.96

1.03

1.0

—

(3017181) Myelocytes/100 leukocytes in Blood

389

3564

1.10

1.03

4.8

4.0

1.1

1.0

0.31

129

1034

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

420

1.29

1.02

2.5

3.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

103

862

1.20

1.02

1.5

1.6

—

(4094501)

1095

0.83

1.02

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

866

8196

1.07

1.02

3.0

3.2

mmol/l

2.5

0.30

768

7147

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

145

1251

1.16

1.01

1.6

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

255

2287

1.12

1.01

3.0

3.3

pmol/l

4.4

0.05

221

1996

(3000492) Spirometry study

386

3540

1.10

1.00

1.6

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

334

3662

0.91

1.00

4.3

3.9

mmol/l

1.2

0.18

289

3191

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

107

1.59

0.99

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

181

1591

1.14

0.99

1.1

titre

45.0

220.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.84

0.98

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

335

1.32

0.98

1.0

1.1

u/ml

7.2

2.5

0.72

134

(3047007) Chlamydophila sp Ab [Presence] in Serum

441

1.27

0.98

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

114

969

1.18

0.97

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

114

969

1.18

0.97

1.4

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

272

2458

1.11

0.95

1.5

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

250

1.36

0.95

1.6

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

149

1.48

0.95

1.5

2.2

e6/l

5467.0

887.6

0.49

105

(3051101) Glucose [Moles/volume] in Cord blood

1.69

0.95

3.2

6.7

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.22

0.93

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

2.22

0.93

1.0

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

963

9175

1.06

0.93

2.9

2.6

e6/l

5.4

0.05

826

8010

(3023420) DNA double strand Ab [Units/volume] in Serum

400

1.28

0.93

1.2

1.4

iu/ml

17.7

26.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

789

1.20

0.93

1.3

miu/ml

161.1

208.8

0.53

319

(1001926) Buprenorphine [Presence] in Urine by Screen method

598

1.22

0.92

2.0

1.9

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

134

1.49

0.91

1.2

1.9

—

26508.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

159

1.45

0.91

3.6

2.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

576

0.78

0.91

1.2

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

598

0.78

0.90

1.2

u/ml

1.9

3.4

1.07

192

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.60

0.90

3.7

2.5

—

(4281824)

463

0.75

0.90

1.0

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

102

0.49

0.89

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

332

1.30

0.89

1.7

1.3

—

(21494755) Public health laboratory ask at order entry panel

214

2382

0.89

0.88

1.4

—

(3026782) Osmolality of Urine

894

8515

1.06

0.88

3.5

2.8

mosm/kgh2o

543.9

547.1

0.16

742

7201

(3036603) Volume of Urine

298

1.31

0.87

1.5

1.7

1755.1

1853.6

0.19

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

103

1.56

0.87

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.58

0.87

1.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

209

1874

1.12

0.86

1.9

2.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

482

0.77

0.86

1.7

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

136

1.47

0.86

1.9

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

136

1.47

0.86

1.9

2.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

285

2600

1.10

0.86

2.2

2.1

nmol/l

13.1

12.0

1.13

228

2257

(44790048)

450

1.25

0.85

1.8

1.3

—

(44806118)

450

1.25

0.85

1.8

1.3

—

(44790047)

450

1.25

0.85

1.8

1.3

—

(44790049)

450

1.25

0.85

1.8

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

299

1.31

0.85

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.94

0.84

1.0

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.59

0.84

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

1.78

0.84

1.1

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

688

1.20

0.83

2.2

2.1

u/l

6004.1

3272.5

0.33

279

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

301

1.30

0.82

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.69

0.82

1.0

2.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

381

1.26

0.82

1.4

u/l

23.8

29.6

0.70

314

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

172

1.40

0.80

2.3

2.7

—

(3019977) pH of Arterial blood

259

1.31

0.79

1.9

2.6

7.5

7.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

233

1.33

0.79

1.3

nmol/l

1.2

0.04

177

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

0.00

0.79

0.0

1.1

—

36.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.67

0.78

1.8

2.1

umol/l

18.9

18.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

115

1000

1.15

0.78

2.2

2.1

g/l

130.7

127.7

0.61

711

(4268621)

394

0.76

2.2

2.3

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

0.76

0.0

1.4

—

0.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

288

1.29

0.75

1.6

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.54

0.75

1.5

1.6

—

(4133840)

1.57

0.74

1.3

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

200

1809

1.11

0.74

2.6

2.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

116

1.47

0.74

1.1

—

(40758292) HTLV I+II Ab panel - Serum

1.64

0.73

1.8

1.4

—

(40768446) Kidney Pathology biopsy report

150

1.40

0.73

1.6

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

325

1.26

0.73

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

200

1811

1.11

0.73

2.6

2.2

g/l

7.7

7.5

0.40

132

1366

(3019832) Treponema pallidum Ab [Presence] in Serum

222

2023

1.10

0.72

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

765

1.17

0.72

1.3

1.2

u/ml

13.5

3.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

148

1657

0.89

0.71

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

609

1.18

0.70

1.5

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

646

1.18

0.70

1.6

1.4

u/ml

107.3

122.5

0.74

128

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

472

1.21

0.70

1.3

nmol/l

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

199

1807

1.11

0.70

2.6

2.2

g/l

3.6

3.8

1.25

124

1312

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.71

0.70

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

1.51

0.69

1.1

1.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

152

1.38

0.69

1.1

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

815

1.16

0.69

4.6

3.7

60.0

58.0

0.71

815

(3018133) Calcium [Moles/volume] in Urine

1.53

0.68

1.8

2.1

mmol/l

2.9

2.8

—

(3002179) Metamyelocytes/100 leukocytes in Blood

349

3254

1.08

0.68

4.7

3.8

0.7

0.6

0.54

743

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1.60

0.68

1.3

1.5

—

146.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

474

0.80

0.67

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

1.63

0.66

1.3

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

119

1.43

0.66

1.9

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.49

0.66

1.8

ug/l

1.5

2.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

790

1.15

0.66

1.2

1.7

nmol/l

0.8

0.05

663

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

223

1.30

0.66

1.6

1.7

u/field

2.8

3.0

0.05

159

(3003129) Base excess in Capillary blood by calculation

111

1.44

0.65

1.3

1.9

mmol/l

0.1

1.4

0.75

102

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

781

7481

1.05

0.65

3.2

2.8

e6/l

1.3

1.2

0.51

468

4266

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

187

1700

1.10

0.65

2.6

2.3

g/l

3.1

0.42

128

1337

(4024509)

422

1.21

0.64

1.4

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

163

1.35

0.64

2.5

2.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.72

0.64

1.2

1.3

nmol/l

3.7

5.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

151

1674

0.90

0.63

3.0

3.3

u/ml

158.9

3665.8

1.33

129

1422

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

305

1.25

0.63

1.5

1.1

titre

90.0

158.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

305

1.25

0.63

1.5

1.1

—

260.0

—

(40761536) Microorganisms panel - Urine sediment

363

3402

1.07

0.63

5.0

4.1

—

(3011288) Drugs identified in Urine by Screen method

515

1.19

0.63

2.8

2.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

682

1.16

0.63

1.3

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

208

1.30

0.61

1.0

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

388

1.21

0.61

1.3

1.6

33.3

29.3

0.24

234

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.60

0.61

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

243

2247

1.09

0.60

5.2

3.5

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.4

—

31.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.60

0.0

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

362

1.22

0.60

1.3

1.5

nmol/l

0.3

0.00

272

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

105

1.43

0.60

6.4

7.5

—

(3025577) Chromium [Mass/volume] in Blood

300

0.77

0.59

2.7

2.1

ug/l

2.3

2.2

0.02

256

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.59

0.0

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

290

1.24

0.59

1.9

1.4

promille

1.0

1.1

0.15

231

(3036489) Thrombin time

141

1561

0.90

0.59

1.9

2.0

21.5

21.6

0.10

125

1374

(3039443) Prostate specific Ag panel - Serum or Plasma

650

0.84

0.59

1.4

1.6

—

(3024869) Neuronal Ab [Presence] in Serum

1.53

0.59

1.3

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

640

1.16

0.58

1.3

1.2

u/ml

306.3

280.7

0.29

393

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

735

0.86

0.58

4.3

3.2

—

(40768793) Breast Pathology biopsy report

927

0.87

0.58

1.4

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

162

0.68

0.58

1.3

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

116

0.60

0.57

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.48

0.57

5.5

4.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.67

0.56

1.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.67

0.56

7.2

4.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

559

1.16

0.56

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

185

1698

1.09

0.56

2.5

2.2

g/l

9.6

10.3

1.26

137

1427

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.62

0.55

4.3

4.6

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.62

0.55

1.5

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.62

0.55

1.0

1.1

—

(3003181) Sodium [Moles/volume] in Urine

766

1.14

0.55

1.4

1.3

mmol/l

58.4

62.0

0.44

612

(3032773) Endomysium IgG Ab [Titer] in Serum

296

0.78

0.55

1.2

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

148

0.68

0.55

1.2

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

505

4810

1.06

0.55

3.5

4.0

ug/l

22.8

25.8

0.11

402

3944

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

941

0.88

0.53

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.48

0.53

11.3

12.3

mmol/l

5.9

5.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

395

1.19

0.53

1.0

1.1

—

4.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

131

1186

1.11

0.53

1.8

2.5

g/l

3.8

3.6

0.71

121

1131

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

404

0.82

0.53

1.2

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.43

0.53

1.2

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

109

1.38

0.50

1.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

380

4008

0.94

0.50

2.5

2.4

u/l

37.3

51.1

0.55

330

3404

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

509

1.16

0.50

1.2

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.41

0.50

6.4

7.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

194

1796

1.08

0.50

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

288

1.22

0.50

2.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

584

0.85

0.49

1.2

u/ml

2.4

3.9

1.74

244

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

127

1.34

0.49

1.2

1.3

ug/l

716.7

357.6

—

(1761868) Lipid panel - Serum or Plasma

1213

12450

0.97

0.49

3.3

3.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

456

1.16

0.48

2.3

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

128

1.33

0.47

1.1

miu/ml

1196.6

1651.5

1.39

128

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.49

0.47

1.0

1.2

—

(1002224) Polysomnography panel

142

1301

1.09

0.47

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

102

1.37

0.47

1.3

95.5

87.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

137

1.32

0.47

1.2

g/l

39.7

39.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

607

1.14

0.46

1.2

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.43

0.46

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.38

0.46

1.2

2.0

—

(3009871) Measles virus Ab [Titer] in Serum

1.38

0.46

1.4

1.8

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

114

1253

0.91

0.45

2.0

2.2

91.0

89.9

0.19

106

1175

(3018095) Leukocytes [#/volume] in Urine

1540

15078

1.03

0.45

4.3

3.8

e6/l

91.7

117.6

0.61

1092

10756

(3035320) C reactive protein [Mass/volume] in Body fluid

309

0.81

0.45

2.4

2.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.43

0.45

2.1

1.8

—

(3022689) Creatine [Moles/volume] in Urine

103

1.36

0.45

1.1

1.4

—

(3024263) Appearance of Synovial fluid

242

0.78

0.44

1.4

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

242

0.78

0.44

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

348

1.18

0.44

2.5

2.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.37

0.44

2.1

2.4

u/field

1.1

0.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

448

0.85

0.43

1.1

1.3

mmol/l

8.2

7.5

0.44

318

(21494434) Karyotype in Bone marrow

395

1.17

0.43

1.3

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

470

1.15

0.43

3.6

3.4

—

(3016750) Collection duration of Urine

263

0.80

0.43

1.9

2.0

min

518.9

496.2

0.58

186

(3022493) Free Hemoglobin [Mass/volume] in Plasma

184

1.25

0.43

1.3

4.3

mg/l

81.4

63.6

0.63

137

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

104

1.35

0.43

1.1

98.8

87.8

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.61

0.43

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.61

0.43

1.6

1.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

818

0.89

0.42

1.7

1.8

nmol/l

44.6

42.4

0.34

790

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.42

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.65

0.42

1.0

1.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

162

0.74

0.42

1.2

1.1

u/ml

—

6.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

736

1.12

0.42

1.4

u/l

9.7

10.9

0.36

602

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

651

1.12

0.42

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

232

2464

0.94

0.41

8.6

mmol/l

24.4

24.3

0.16

196

2287

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

305

0.82

0.41

2.1

1.7

—

(3004775) Volume in Urine collected for unspecified duration

360

1.17

0.41

1.8

2.2

618.3

653.2

0.23

227

(3021440) Promyelocytes/100 leukocytes in Blood

356

3394

1.05

0.41

4.8

4.0

0.1

0.08

117

970

(3045716) Anion gap in Serum or Plasma

222

1.22

0.41

2.8

2.2

mmol/l

9.5

9.2

0.16

178

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

260.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

204

1.23

0.40

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

223

1.21

0.39

1.2

1.3

—

(3035880) pH of Pleural fluid

260

1.19

0.39

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

297

1.18

0.39

1.1

1.0

mg/l

280.8

290.6

0.37

266

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

121

1313

0.92

0.39

2.2

g/l

0.0

0.36

106

1178

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

104

951

1.10

0.39

1.7

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

187

1.23

0.38

5.8

5.4

u/ml

36.2

54.0

—

(3012501) Base excess in Blood by calculation

105

961

1.09

0.38

4.9

4.4

mmol/l

2.5

2.7

0.18

676

(3006462) Nitrate [Presence] in Urine

197

1.22

0.37

2.7

3.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.33

0.37

2.2

2.8

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.35

0.37

2.2

1.8

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.35

0.37

1.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

225

1.20

0.37

1.2

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

134

1.27

0.36

1.2

1.9

e6/l

882.7

20932.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.64

0.35

1.2

—

(3016228) CD19 cells/100 cells in Blood

171

1.23

0.35

2.6

2.1

4.9

7.7

0.83

163

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.43

0.35

1.8

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

212

0.80

0.35

1.0

1.2

ratio

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

338

1.16

0.35

1.0

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

106

1149

0.92

0.35

2.2

2.4

195.8

199.4

0.19

1087

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.36

0.34

1.2

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.36

0.34

1.0

1.2

umol/24h

1.5

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

218

1.19

0.34

1.0

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

104

959

1.09

0.34

1.3

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.33

0.33

1.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

120

1291

0.93

0.33

2.2

g/l

0.0

0.00

106

1174

(40768800) Prostate Pathology biopsy report

959

0.92

0.33

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.30

0.33

1.2

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.30

0.33

1.0

1.5

—

(4306422)

572

0.89

0.33

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

299

2861

1.05

0.32

8.2

8.5

1.3

0.13

299

2840

(3011985) Renin [Units/volume] in Plasma

530

1.11

0.32

1.5

1.4

mu/l

27.5

62.0

2.45

475

(3008295) Osmolality of Serum or Plasma

426

1.13

0.32

1.3

mosm/kgh2o

281.9

279.2

0.28

326

(3042111) Morphology [Interpretation] in Bone marrow Narrative

790

0.91

0.32

1.8

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

119

1.26

0.31

1.3

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

316

0.85

0.31

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

106

983

1.08

0.31

1.7

1.8

—

(3020491) Glucose [Moles/volume] in Blood

295

1.15

0.31

1.2

2.3

mmol/l

7.5

6.8

0.50

200

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

232

2434

0.95

0.30

1.4

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

131

0.76

0.30

1.0

1.1

—

(3021589) Normoblasts [#/volume] in Blood

1824

17995

1.02

0.30

10.5

9.9

e9/l

0.0

0.10

1495

14603

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

725

1.09

0.30

1.3

1.2

u/ml

24.9

47.0

1.20

(3013293) Extractable nuclear Ab [Presence] in Serum

1.27

0.30

2.6

1.7

—

(3022621) pH of Urine by Test strip

291

2792

1.04

0.29

3.3

3.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

119

1114

1.07

0.28

3.6

3.3

mmol/l

25.2

0.05

967

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

111

0.72

0.28

1.5

1.9

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

403

3897

1.04

0.28

1.8

1.5

0.01

345

3348

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

103

1.26

0.28

1.0

1.1

—

(3034426) Prothrombin time (PT)

129

0.77

0.28

1.1

1.3

—

(4198724)

1.28

0.28

1.8

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

149

1.21

0.27

1.1

1.2

—

(3015183) Erythrocyte sedimentation rate

149

1.21

0.27

1.6

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

166

1574

1.06

0.27

2.5

2.3

g/l

1.1

0.9

0.20

131

1336

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

224

1.16

0.27

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.30

0.26

1.7

3.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

587

1.09

0.26

1.3

1.5

e6/l

1524.3

2167.9

0.76

419

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

225

1.16

0.26

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.67

0.25

1.0

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.25

0.25

6.2

7.4

—

(4211845)

216

1.16

0.25

2.6

3.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

747

0.92

0.25

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.26

0.24

1.5

1.2

—

(40765096) Chromosome analysis panel by Banding

124

1.21

0.24

1.1

—

(3044007) Cell count panel - Peritoneal fluid

124

1.21

0.24

1.3

2.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

246

1.14

0.23

1.5

1.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

284

1.13

0.23

1.9

1.8

—

(3052851) Hemolysis interference index of Serum or Plasma

142

1349

1.05

0.23

3.4

—

(3023410) Appearance of Cerebral spinal fluid

380

1.11

0.23

1.2

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

174

1664

1.05

0.22

3.7

3.0

u/ml

0.3

1.08

113

939

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

323

1.12

0.22

4.0

4.9

u/ml

431.5

112.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

285

1.12

0.22

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

285

1.12

0.22

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

285

1.12

0.22

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.25

0.22

1.2

1.1

—

(3025159) Blasts/100 leukocytes in Blood

329

3190

1.03

0.22

4.9

4.0

0.6

0.2

0.33

102

799

(3000012) Reticulocyte production index

238

1.14

0.22

1.7

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

144

1.18

0.22

1.2

1.1

—

0.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

885

1.06

0.21

2.2

2.7

umol/l

33.7

34.7

0.15

743

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.19

0.21

1.4

2.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

3.1

—

1.5

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3033799) Differential panel - Peritoneal fluid

135

1.19

0.21

2.1

1.9

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.1

—

5.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

392

1.10

0.21

2.2

1.9

—

1.2

—

(3020650) Glucose [Presence] in Urine

105

0.76

0.21

1.8

1.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.21

0.0

4.5

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

294

2850

1.03

0.21

8.3

8.6

0.7

0.31

294

2826

(3028308) Erythrocytes [#/volume] in Pleural fluid

538

1.08

0.20

1.3

1.4

e6/l

22625.1

52139.6

1.31

317

(3037556) Urate [Mass/volume] in Serum or Plasma

136

1.18

0.20

1.3

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.21

0.19

1.2

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

127

1.18

0.19

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

260

0.88

0.19

1.3

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

279

1.11

0.19

2.4

1.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

146

1.16

0.19

1.1

ng/l

47.4

548.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

194

1.13

0.18

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

112

1068

1.05

0.18

1.2

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

243

1.11

0.17

1.0

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

660

1.06

0.16

1.3

1.5

g/l

30.6

31.9

0.37

591

(3014891) Appearance of Pleural fluid

0.71

0.16

1.6

1.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

101

1.19

0.16

1.1

pmol/l

291.5

318.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

311

1.09

0.16

1.8

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

131

1258

1.04

0.16

1.4

ug/g

270.3

265.1

0.11

770

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.13

0.16

1.8

1.5

ng/l

111.3

142.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

109

1044

1.05

0.15

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.14

0.15

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

361

1.08

0.15

1.4

1.5

—

(3004451) EKG impression Narrative

236

1.10

0.14

1.2

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1023

0.96

0.14

1.4

1.3

—

(1616796) Gas panel - Central venous blood

101

969

1.04

0.14

4.6

3.8

—

(3013637) Mi-2 Ab [Presence] in Serum

103

1.17

0.13

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

103

1.17

0.13

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

103

1.17

0.13

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

103

1.17

0.13

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

305

0.92

0.13

1.3

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

135

1396

0.97

0.13

2.4

2.1

g/l

0.0

0.32

120

1257

(3016038) Potassium [Moles/volume] in Urine

286

1.08

0.13

1.2

mmol/l

34.6

34.3

0.02

241

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

210

2047

1.03

0.13

2.8

4.0

u/ml

80.8

62.9

0.27

199

1963

(3043238) Trisomy 21 risk [Likelihood] in Fetus

324

0.93

0.12

1.4

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

200

1.10

0.12

1.0

1.1

u/l

1.2

1.1

0.51

103

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

212

2171

0.98

0.12

5.4

4.1

mmol/l

24.0

24.1

0.21

178

1954

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

317

1.07

0.12

1.3

1.4

u/l

12.2

13.2

0.53

305

(3012441) Differential panel - Pleural fluid

514

1.05

0.11

1.3

1.5

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

115

0.87

0.10

1.2

2.0

178.4

174.0

—

110

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

444

0.95

0.10

1.1

u/ml

2.9

2.6

0.09

169

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

495

1.05

0.10

1.3

pmol/l

226.4

270.9

0.66

383

(40768806) Pleura Pathology biopsy report

505

1.05

0.10

1.3

1.6

—

(3010421) pH of Blood

117

1136

1.03

0.10

4.8

4.2

7.4

0.61

102

945

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.06

0.09

1.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.04

0.09

1.4

2.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.04

0.09

1.0

2.8

mmol/l

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

360

1.06

0.09

1.9

2.0

u/field

3.1

1.8

0.58

133

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

961

1.03

0.09

2.3

3.4

u/ml

318.7

725.8

0.54

885

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.11

0.09

1.5

—

(3000285) Sodium [Moles/volume] in Blood

1.05

0.08

1.0

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.79

0.08

5.0

3.7

umol/l

33.6

40.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

234

1.07

0.08

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

234

1.07

0.08

1.5

1.6

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

283

1.06

0.08

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

283

1.06

0.08

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.06

0.08

1.1

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.06

0.08

1.0

1.2

—

(3000991) Gas panel - Venous blood

374

3784

0.99

0.07

8.7

7.9

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

284

1.06

0.07

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.03

0.07

1.0

—

(40767503) Oxygen content in Capillary blood by calculation

926

1.03

0.07

2.9

2.5

16.6

16.0

0.90

486

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.83

0.07

1.7

1.2

—

(36304419) Bacteria [Presence] in Urine

1166

11722

0.99

0.07

3.6

3.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

316

0.95

0.07

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

122

0.90

0.07

1.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

1014

0.98

0.07

2.3

—

(3002582) Erythrocytes [#/volume] in Urine

1321

13147

1.01

0.07

3.8

3.3

e6/l

137.7

75.8

0.32

1006

10082

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.12

0.06

1.7

1.5

—

(40757373) Influenza virus identified in Isolate

0.85

0.06

1.1

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

142

0.92

0.06

1.2

1.0

—

(3005033) Fetal Nuchal fold Thickness US

315

0.95

0.06

1.4

—

(40768795) Lymph node Pathology biopsy report

416

0.96

0.06

1.3

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

119

1.09

0.06

1.0

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

147

1446

1.02

0.05

2.0

2.1

g/l

37.4

37.2

0.11

114

1231

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

395

1.04

0.05

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

188

1.06

0.05

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

556

0.97

0.05

3.0

2.3

u/ml

2473.5

584.5

0.36

540

(3035637) Corticotropin [Mass/volume] in Plasma

485

1.03

0.05

2.1

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

103

1049

0.98

0.05

4.9

3.4

mg/l

1.6

0.21

958

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

704

7002

1.01

0.05

3.5

3.0

e6/l

2.5

0.02

389

3808

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

127

1250

1.02

0.05

1.9

1.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

595

1.03

0.04

1.1

iu/ml

29.4

1312.3

0.73

134

(3033658) Prothrombin time (PT) actual/Normal

1086

10901

1.00

0.04

4.1

4.0

87.5

87.6

0.07

1054

10645

(3024928) Oxygen saturation in Venous blood

927

0.98

0.04

3.8

3.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

987

0.98

0.04

1.1

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

150

0.93

0.04

4.6

3.0

54.8

53.2

0.10

145

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

150

0.93

0.04

2.5

1.9

ug/l

23.7

250.4

0.65

139

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

564

0.97

0.04

1.2

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

119

1173

1.01

0.04

2.1

1.7

mg/l

4.5

3.2

0.36

836

(40768441) Liver Pathology biopsy report

291

0.96

0.04

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

724

0.98

0.03

1.7

1.2

u/l

64.5

39.9

0.60

629

(3014111) Lactate [Moles/volume] in Serum or Plasma

393

3954

0.99

0.03

6.9

6.6

mmol/l

1.3

1.4

0.17

379

3807

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

108

1095

0.99

0.03

2.3

ug/min

159.6

102.6

0.52

650

(3025018) Bordetella pertussis Ab [Titer] in Serum

189

0.95

0.03

1.3

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

189

0.95

0.03

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

231

1.04

0.02

1.2

—

(3017569) Oxygen content in Arterial blood

239

0.96

0.02

2.0

2.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

202

1.04

0.02

1.2

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

441

1.02

0.02

1.2

1.4

mmol/l

6.5

6.4

0.19

409

(3015076) Soybean IgE Ab [Units/volume] in Serum

107

0.93

0.02

1.0

—

0.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

619

0.99

0.02

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

388

0.98

0.01

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

388

0.98

0.01

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

388

0.98

0.01

1.5

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

143

1.05

0.01

2.7

2.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

418

0.98

0.01

1.4

1.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

102

1011

1.01

0.01

4.8

3.1

kpa

8.1

8.0

0.24

938

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

213

1.03

0.01

1.6

1.4

pmol/l

53.9

217.1

0.54

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

453

4542

1.00

0.01

3.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

387

0.98

0.01

1.4

—

(3045788) Cell count panel - Pleural fluid

467

0.98

0.01

1.4

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

124

1.05

0.00

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

194

1.03

0.00

1.5

1.3

—

(3045142) Bone marrow Pathology biopsy report

506

0.99

0.00

1.5

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

626

0.99

0.00

1.1

—

(3021901) Oxygen saturation in Capillary blood

824

1.01

0.00

3.9

2.9

—

(3030467) Casts [#/volume] in Urine by Automated count

1208

12086

1.00

0.00

3.8

3.2

e6/l

0.4

0.5

0.85

910

9117

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

105

0.95

0.00

1.2

1.1

—

(3011648) Oxygen content in Venous blood

328

1.01

0.00

2.6

10.9

0.03

328

(3043410) Blood group antigens tested for on Red Blood Cells

106

1.04

0.00

2.1

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

144

0.97

0.00

1.6

2.7

umol/l

149.8

139.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

103

0.97

0.00

1.4

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

204

0.98

0.00

1.2

—

(3047189) Immunofixation for 24 hour Urine

236

1.02

0.00

1.4

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

227

1.01

0.00

5.6

6.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

926

1.00

0.00

1.6

1.8

iu/l

3.2

4.7

1.54

308

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

189

1.01

0.00

1.1

2.5

100.9

96.9

0.17

179

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

230

2303

1.00

0.00

1.2

iu/ml

161.1

142.2

0.31

827

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

559

1.00

0.00

2.9

2.1

32.8

0.00

552

(40765089) Chromosome analysis panel - Blood by G-banded

1.00

0.00

1.0

—

(4212803)

0.91

0.00

1.0

1.1

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1778.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.98

0.00

1.0

1.1

u/ml

36.4

45.6

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.93

0.00

1.6

1.7

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.3

—

1650.7

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

2.3

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

9.4

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.95

0.00

1.0

1.3

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_HL_MIX_NAS and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_HL_MIX_NAS	0.993 [0.92, 1.07]	0.846
Birth year	0.994 [0.99, 1.0]	0.124

During the follow-up period (1.1.1998 — 31.12.2019), 4413 out of 18401 females with H8_HL_MIX_NAS died.

Males

Parameter	HR [95% CI]	p-value
H8_HL_MIX_NAS	0.992 [0.91, 1.08]	0.842
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 4113 out of 15201 males with H8_HL_MIX_NAS died.

Mortality risk

Mortality risk for people of age

years, who have H8_HL_MIX_NAS.

N-year risk	Females	Males
1	0.082%	0.181%
5	0.554%	1.226%
10	1.44%	3.036%
15	2.885%	5.615%
20	4.912%	9.624%

Relationships between endpoints

↥

Index endpoint: H8_HL_MIX_NAS – Mixed conductive and sensorineural hearing loss

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Mixed conductive and sensorineural hearing loss

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints